Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection.
D003663:Decision Trees; D024882:Drug Resistance, Viral / Q000235:genetics; D005260:Female; D015683:Gene Products, gag / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D016333:HIV Protease / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015497:HIV-1 / Q000145:classification / Q000201:enzymology / Q000235:genetics* / Q000502:physiology*; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic / Q000235:genetics*; D015203:Reproducibility of Results; D019438:Ritonavir / Q000494:pharmacology / Q000627:therapeutic use; D013268:Stimulation, Chemical; D014779:Virus Replication / Q000187:drug effects*
D015683:Gene Products, gag; D017320:HIV Protease Inhibitors; D016333:HIV Protease; D019438:Ritonavir